Replies to post #95615 on Biotech Values

[genisi]

Perhaps MRK is trying to back up its argument for the arbitration with JNJ regarding rights to Remicade. MRK is claiming that the merger was structured in reverse so Schering purchased Merck and this is the "New Merck" and therefore does not violate the contract between Schering and JNJ,.